In vivo KCNQ1-suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome

por Giammarino, L, Nimani, S, Bains, S, Alerni, N, Tester, D J, Christoforou, N, Louradour, J, Jurgensen, J, Barry, M A, Koren, G, Zehender, M, Brunner, M, Brooks, G, Ackerman, M J, Odening, K E
Publicado 2023

Ventricular conduction is a marker for arrhythmic risk in overlap sodium channel disease

por Wijeyeratne, Y, Tanck, M W, Mckeown, P P, Probst, V, Crotti, L, Page, S, Galvin, J, Petzer, E, Horie, M, Roden, D, Veltmann, C, Makita, N, Aiba, T, Ackerman, M J, Behr, E R
Publicado 2023

Flecainide is associated with a reduction in arrhythmic events in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia

por Bergeman, A T, Tanck, M W, Kallas, D, Sanatani, S, Leenhardt, A, Ackerman, M J, Till, J, Zorio, E, Kannankeril, P J, Kammeraad, J A E, Aiba, T, Semsarian, C, Robyns, T, Wilde, A A M, Van Der Werf, C
Publicado 2023